- Home
- KIND vs PHAR Comparison
KIND vs PHAR Comparison
Compare KIND & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIND
- PHAR
- Stock Information
- Founded
- KIND 2011
- PHAR 1988
- Country
- KIND United States
- PHAR Netherlands
- Employees
- KIND N/A
- PHAR N/A
- Industry
- KIND Computer Software: Programming Data Processing
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- KIND Technology
- PHAR Health Care
- Exchange
- KIND Nasdaq
- PHAR Nasdaq
- Market Cap
- KIND 544.2M
- PHAR 587.5M
- IPO Year
- KIND N/A
- PHAR N/A
- Fundamental
- Price
- KIND $1.37
- PHAR $10.03
- Analyst Decision
- KIND Buy
- PHAR Strong Buy
- Analyst Count
- KIND 3
- PHAR 3
- Target Price
- KIND $2.75
- PHAR $30.00
- AVG Volume (30 Days)
- KIND 1.9M
- PHAR 3.0K
- Earning Date
- KIND 05-07-2025
- PHAR 05-08-2025
- Dividend Yield
- KIND N/A
- PHAR N/A
- EPS Growth
- KIND N/A
- PHAR N/A
- EPS
- KIND N/A
- PHAR N/A
- Revenue
- KIND $248,306,000.00
- PHAR $320,708,000.00
- Revenue This Year
- KIND $5.45
- PHAR $12.39
- Revenue Next Year
- KIND $11.79
- PHAR $9.84
- P/E Ratio
- KIND N/A
- PHAR N/A
- Revenue Growth
- KIND 12.01
- PHAR 24.13
- 52 Week Low
- KIND $1.35
- PHAR $6.65
- 52 Week High
- KIND $3.00
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- KIND 33.51
- PHAR 71.76
- Support Level
- KIND $1.35
- PHAR $8.60
- Resistance Level
- KIND $1.57
- PHAR $10.28
- Average True Range (ATR)
- KIND 0.08
- PHAR 0.30
- MACD
- KIND 0.01
- PHAR 0.17
- Stochastic Oscillator
- KIND 6.82
- PHAR 88.79
About KIND Nextdoor Holdings Inc.
Nextdoor Holdings Inc is the platform to connect to the neighborhoods. The purpose is to cultivate a kinder world where everyone has a neighborhood. Neighbors around the world turn to Nextdoor daily to receive trusted information, give and get help, get things done, and build real-world connections with nearby neighbors, businesses, and public services. It offers a comprehensive suite of advertising solutions designed to deliver exceptional value for businesses of all size.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.